戻る Agenda
Emerging Guidances for Companion Diagnostics and Co-development
Session Chair(s)
Jeffrey N. Stuart, PHD
Associate Vice President, Global Regulatory Affairs
Merck Sharp & Dohme LLC , United States
Technologies supporting breakthrough therapies and their companion diagnostics are rapidly evolving, and global regulation is attempting to keep pace with fast-moving innovation in this field. This session will forecast how emerging global health authority regulations and guidance may evolve and what companies should be considering to prepare.
Speaker(s)
Speakers
Mya Thomae, RAC
Myraqa, United States
Founder and Chief Executive Officer
Speakers
Erik Vollebregt, JD, LLM
AXON Lawyers, Netherlands
Partner